Astragaloside II

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Astragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy.

Astragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Astragaloside II also induces osteogenic activities, differentiation, proliferation, and mineralization, through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.

Astrasieversianin VIII

Others

Other Targets

Smad1; Smad5; Smad8

Others-Field

——

84676-89-1

798.95

C41H66O15

98%

DMSO : 100 mg/mL 120.92 mM; H2O : < 0.1 mg/mL

C(=O)(C)O[C@H]1[C@@H](OC[C@H]([C@@H]1O)O)O[C@H]1CC[C@]23C4(CC[C@]5([C@]([C@@H]4C[C@@H]([C@H]2C1(C)C)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)(C[C@@H]([C@@H]5[C@@]1(O[C@@H](CC1)C(C)(C)O)C)O)C)C)C3

——

(-20℃)

With Ice Pack

≥ 2 years